Devices, drugs, and the Food and Drug Administration - Increasing implications for ischemic stroke

被引：14
作者：
Furlan, AJ
Fisher, M
机构：
[1] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA
[2] Cleveland Clin, Dept Neurol, Head Sect Stroke & Neurocrit Care, Cleveland, OH 44106 USA
来源：
STROKE | 2005年 / 36卷 / 02期
关键词：
acute care; stroke; ischemic;
D O I：
10.1161/01.STR.0000153057.07181.94
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：398 / 399
页数：2
相关论文
共 7 条
  • [1] *DEP HLTH HUM SERV, 2000, P NEUR DEV PAN 15 M
  • [2] Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial
    Furlan, A
    Higashida, R
    Wechsler, L
    Gent, M
    Rowley, H
    Kase, C
    Pessin, M
    Ahuja, A
    Callahan, F
    Clark, WM
    Silver, F
    Rivera, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2003 - 2011
  • [3] Levin S, 2004, IN VIVO BUSINESS MED, V18
  • [4] SMITH JJ, 2000, DEFINING LEAST BURDE
  • [5] *STROK THER AC IND, 2005, IN PRESS STROKE
  • [6] TEMPLE R, 1993, FINAL REPORT COMMITT
  • [7] 2004, GRAY SHEET, V30
1